PTC Therapeutics (PTCT) PT Lowered to $42 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $70.56 +1.47%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $42.00 (from $45.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- NIO Inc (9866:HK) (NIO) PT Lowered to HK$54.40 at Citi
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
